Researchers uncover the mechanism behind how a subset of NSAIDs reduces inflammation, which helps explain some of the curious side effects of the anti-inflammatories.
Anakinra, a clinically approved anti-inflammatory used to treat rheumatoid arthritis, improves respiratory function in patients with severe COVID-19 infection.
Researchers found no evidence NSAIDs, such as ibuprofen, may result in worse outcomes for some COVID-19 patients or help control the virus. TNF blockers and JAK inhibitors, used to treat inflammation and arthritis, were also found to be safe to use. However, low amounts of prednisolone or tacrolimus therapy may be useful in treating coronavirus infection.
Capsular polysaccharide A (PSA), an envelope molecule, may help to boost the immune system and protect against potentially fatal neuroinflammation associated with Herpes Simplex Encephalitis (HSE). Mice given PSA survived exposure to a lethal herpes simplex viral infection, while those not treated with the probiotic did not, despite both groups being treated with a common antiviral used to treat HSE.
Anti-inflammatory medications, such as those commonly prescribed for arthritis, improve depressive symptoms in those with MDD.
The use of naproxen, an NSAID anti-inflammatory, increases the frequency of adverse health effects and does not reduce the risk of developing Alzheimer's disease.
Scientist reveal a drug regiment consisting of anti-inflammatories and anti-stress medications given before and after surgery could reduce cancer recurrence.
A new study in PNAS reveals how the body converts omega 3 fatty acids into endocannabinoids, which can have anti-inflammatory effects.
Researchers report lower Omega 3 levels in veterans who expressed an increased risk of being depressed or suicidal.
A new study reports a commonly used NSAID anti-inflammatory drug was able to reverse memory loss in mouse models of Alzheimer's disease.
